As a preclinical-stage vaccine company, our business philosophy is to carefully select, license and partner with committed, well funded, high-integrity organizations and pharmaceutical / vaccine companies who are aligned with our principles of timely research, development, regulatory approval and worldwide product launch. We believe this is the most efficient, effective and attractive method to ensure that our many novel somatostatin vaccine based treatment solutions will ultimately get into the hands of those who need them on a timely basis.

"Braasch is actively involved in selecting attractive licensing partners for our technologies."

Copyright © 2010 Braasch Biotech LLC. All rights reserved.
Webmaster